FLT1 and preeclampsia: Furthermore, some studies have shown that circulating levels of soluble fms-like tyrosine kinase-1 (sFLT1), a soluble variant of the vascular endothelial growth factor receptor (VEGFR1), are increased in patients with preeclampsia [19].